A. Alper Öztürk

976 total citations
46 papers, 775 citations indexed

About

A. Alper Öztürk is a scholar working on Pharmaceutical Science, Biomaterials and Food Science. According to data from OpenAlex, A. Alper Öztürk has authored 46 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmaceutical Science, 17 papers in Biomaterials and 9 papers in Food Science. Recurrent topics in A. Alper Öztürk's work include Advanced Drug Delivery Systems (25 papers), Nanoparticle-Based Drug Delivery (16 papers) and Advancements in Transdermal Drug Delivery (13 papers). A. Alper Öztürk is often cited by papers focused on Advanced Drug Delivery Systems (25 papers), Nanoparticle-Based Drug Delivery (16 papers) and Advancements in Transdermal Drug Delivery (13 papers). A. Alper Öztürk collaborates with scholars based in Türkiye, Czechia and Switzerland. A. Alper Öztürk's co-authors include Behiye Şenel, Hülya Tuba Kıyan, Evrim Yenilmez, Yasemin Yazan, Ebru Başaran, Müzeyyen Demirel, Şenay Sarıca, Cordin Arpagaus, Ozan Özışık and Meliha Ekinci and has published in prestigious journals such as Scientific Reports, Polymers and Journal of Cellular and Molecular Medicine.

In The Last Decade

A. Alper Öztürk

42 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Alper Öztürk Türkiye 17 389 259 136 134 122 46 775
Joana R. Campos Portugal 11 175 0.4× 147 0.6× 161 1.2× 102 0.8× 104 0.9× 19 691
Riham I. El-Gogary Egypt 12 162 0.4× 251 1.0× 221 1.6× 65 0.5× 143 1.2× 20 723
Minyan Wei China 18 295 0.8× 234 0.9× 467 3.4× 117 0.9× 194 1.6× 38 1.2k
Khaled Shalaby Saudi Arabia 19 463 1.2× 205 0.8× 233 1.7× 102 0.8× 97 0.8× 40 1.0k
Jin Han China 21 381 1.0× 176 0.7× 207 1.5× 94 0.7× 93 0.8× 52 920
Mohammed Muqtader Ahmed Saudi Arabia 22 436 1.1× 238 0.9× 247 1.8× 111 0.8× 136 1.1× 81 1.1k
Luciana Facco Dalmolin Brazil 11 220 0.6× 222 0.9× 179 1.3× 63 0.5× 96 0.8× 21 686
João Dias-Ferreira Portugal 14 270 0.7× 173 0.7× 161 1.2× 85 0.6× 137 1.1× 19 782
Behzad Sharif Makhmalzadeh Iran 22 407 1.0× 243 0.9× 177 1.3× 230 1.7× 112 0.9× 59 1.1k
Kanika Thakur India 19 445 1.1× 208 0.8× 223 1.6× 166 1.2× 77 0.6× 60 1.0k

Countries citing papers authored by A. Alper Öztürk

Since Specialization
Citations

This map shows the geographic impact of A. Alper Öztürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Alper Öztürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Alper Öztürk more than expected).

Fields of papers citing papers by A. Alper Öztürk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Alper Öztürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Alper Öztürk. The network helps show where A. Alper Öztürk may publish in the future.

Co-authorship network of co-authors of A. Alper Öztürk

This figure shows the co-authorship network connecting the top 25 collaborators of A. Alper Öztürk. A scholar is included among the top collaborators of A. Alper Öztürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Alper Öztürk. A. Alper Öztürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Öztürk, A. Alper, et al.. (2025). Multiparametric analysis of functional group–performance relationships in tannic acid-based hydrogels from a pharmaceutical technology standpoint. Journal of Drug Delivery Science and Technology. 113. 107352–107352.
3.
Kömür, Mustafa, Hülya Tuba Kıyan, & A. Alper Öztürk. (2025). Development of donepezil hydrochloride-loaded PLGA-based nanoparticles for Alzheimer’s disease treatment. Scientific Reports. 15(1). 13184–13184. 4 indexed citations
4.
5.
Öztürk, A. Alper, et al.. (2024). Enhanced anti-angiogenic effects of aprepitant-loaded nanoparticles in human umbilical vein endothelial cells. Scientific Reports. 14(1). 19837–19837. 6 indexed citations
6.
7.
Öztürk, A. Alper, Ebru Başaran, Behiye Şenel, Müzeyyen Demirel, & Şenay Sarıca. (2023). Synthesis, characterization, antioxidant activity of Quercetin, Rutin and Quercetin-Rutin incorporated β-cyclodextrin inclusion complexes and determination of their activity in NIH-3T3, MDA-MB-231 and A549 cell lines. Journal of Molecular Structure. 1282. 135169–135169. 12 indexed citations
8.
Öztürk, A. Alper & Cordin Arpagaus. (2021). Nano Spray-Dried Drugs for Oral Administration: A Review. Assay and Drug Development Technologies. 19(7). 412–441. 19 indexed citations
10.
Öztürk, A. Alper, et al.. (2020). Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and in vivo anti-inflammatory effect by using HET-CAM assay. Drug Development and Industrial Pharmacy. 46(4). 682–695. 36 indexed citations
11.
Öztürk, A. Alper, et al.. (2020). Levocetirizine Dihydrochloride-Loaded Chitosan Nanoparticles: Formulation and <i>In Vitro</i> Evaluation. Turkish Journal of Pharmaceutical Sciences. 17(1). 27–35. 39 indexed citations
12.
Öztürk, A. Alper, Evrim Yenilmez, Rana Arslan, Behiye Şenel, & Yasemin Yazan. (2020). Dexketoprofen trometamol loaded solid lipid nanoparticles (SLNs): Formulation, in vitro and in vivo evaluation. Journal of Research in Pharmacy. 24(1). 1–18. 14 indexed citations
13.
Öztürk, A. Alper, et al.. (2020). Design of cefaclor monohydrate containing nanoparticles with extended antibacterial effect by Nano-Spray dryer: A Nanoenglobing study. Journal of Research in Pharmacy. 24(1). 1–12. 13 indexed citations
14.
Öztürk, A. Alper, Evrim Yenilmez, & Yasemin Yazan. (2019). Dexketoprofen trometamol-loaded eudragit® rl 100 nanoparticle formulation, characterization and release kinetics. 57(1). 69–69. 16 indexed citations
15.
Öztürk, A. Alper, et al.. (2019). Spray-dried Ketoprofen Lysine-incorporated PLGA Nanoparticles; Formulation, Characterization, Evaluation and Cytotoxic Profile. Indian Journal of Pharmaceutical Sciences. 81(4). 8 indexed citations
17.
Çetin, Aysun, et al.. (2018). Comparison of ELISA and flow cytometry for measurement of interleukin-1 beta, interleukin-6 and tumor necrosis factor-α. Turkish Journal of Biochemistry. 43(5). 540–548. 9 indexed citations
18.
Öztürk, A. Alper, et al.. (2018). New approach to hypertension treatment: Carvediol-loaded PLGA nanoparticles, preparation, in vitro characterization and gastrointestinal stability. 12 indexed citations
19.
Öztürk, A. Alper, et al.. (2018). Effects of different derivatives of eudragit polymer on entrapment efficiency, in vitro dissolution, release kinetics and cell viability results on extended release flurbiprofen loaded nanomedicines. 12 indexed citations
20.
Öztürk, A. Alper, et al.. (2018). Supervised Machine Learning Algorithms for Evaluation of Solid Lipid Nanoparticles and Particle Size. Combinatorial Chemistry & High Throughput Screening. 21(9). 693–699. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026